Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
3.430
+0.080 (2.39%)
Apr 17, 2026, 9:45 AM EDT - Market open
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $335.7 million as of April 17, 2026. Its market cap has increased by 257.89% in one year.
Market Cap
335.70M
Enterprise Value
199.33M
1-Year Change
257.89%
Ranking
Category
Stock Price
$3.43
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $335.70M, a decrease of -48.33%. That is a compound annual growth rate of -6.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 327.90M | 63.87% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 356.70M |
| Zentalis Pharmaceuticals | 356.07M |
| Surrozen | 348.28M |
| NervGen Pharma | 336.67M |
| Cellectis | 318.68M |
| Anavex Life Sciences | 315.08M |
| NovaBridge Biosciences | 308.78M |
| Abeona Therapeutics | 306.92M |